Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in Brazil has been experiencing steady growth in recent years, driven by customer preferences for natural and herbal remedies, increasing awareness of digestive health, and a growing aging population. Customer preferences in the Digestive & Intestinal Remedies (Pharmacies) market in Brazil have been shifting towards natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceuticals. This preference for natural remedies is also influenced by the perception that they have fewer side effects and are more sustainable for long-term use. As a result, there has been a rise in demand for products such as herbal teas, probiotics, and digestive enzymes. Another factor contributing to the growth of the Digestive & Intestinal Remedies (Pharmacies) market in Brazil is the increasing awareness of digestive health. With the prevalence of digestive disorders such as irritable bowel syndrome and acid reflux, consumers are seeking solutions to alleviate symptoms and improve overall gut health. This has led to a surge in demand for products that target specific digestive issues, such as antacids, laxatives, and anti-diarrheal medications. The aging population in Brazil is also driving the growth of the Digestive & Intestinal Remedies (Pharmacies) market. As people age, they are more prone to digestive problems and are more likely to seek remedies to alleviate symptoms. The elderly population in Brazil is growing, which has created a larger customer base for digestive and intestinal remedies. This demographic trend is expected to continue in the coming years, further fueling the growth of the market. In addition to these customer preferences, there are also local special circumstances that are influencing the development of the Digestive & Intestinal Remedies (Pharmacies) market in Brazil. The country has a rich tradition of herbal medicine and natural remedies, which has contributed to the popularity of these products. Brazilian consumers have a strong belief in the healing power of nature and are more inclined to trust traditional remedies. This cultural preference has created a favorable environment for the growth of the market. Underlying macroeconomic factors also play a role in the development of the Digestive & Intestinal Remedies (Pharmacies) market in Brazil. The country has been experiencing economic growth in recent years, which has led to an increase in disposable income. As a result, consumers have more purchasing power and are able to afford higher-priced remedies. This has contributed to the growth of the market, as consumers are willing to invest in products that they perceive as beneficial to their health. Overall, the Digestive & Intestinal Remedies (Pharmacies) market in Brazil is developing due to customer preferences for natural and herbal remedies, increasing awareness of digestive health, a growing aging population, local cultural preferences, and underlying macroeconomic factors. These trends are expected to continue driving the growth of the market in the coming years.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
